Abstract Oral Presentation Session III
论文报告第三场

1:30 PM-3:00 PM Thursday, March 30, 2017

2017年03月30日 星期四   1:30 PM-3:00 PM

Room 303AB, Level 3

三层303AB会议室

  
Moderator 主持人 Weifeng Shen 沈卫峰, Yida Tang 唐熠达, Fuchun Zhang 张福春, Xiaofan Wu 吴小凡

1:30 PM-

AS-0001: Phenomenon of Hyaline Arteriosclerosis with Glagovian Artery Remodeling after Implantation of Bioresorbable Vascular Scaffold: A Serial Multimodality Imaging Analysis of ABSORB Cohort B1 Trial
AS-0001:生物可吸收支架植入术后玻璃样动脉粥样硬化伴随格氏重构现象:ABSORB Cohort B1临床试验的系列多重影像分析
Alexander Kharlamov

1:40 PM-

Q&A
讨论

1:45 PM-

AS-0005: The Serial Platelet Function Testing Predicts Long-term Prognosis Among Patients Undergoing Complex Percutaneous Coronary Intervention
AS-0005:血小板功能系列检测对接受复杂经皮冠状动脉介入治疗患者临床结局的预测价值
Mengmeng Li 李梦梦

1:55 PM-

Q&A
讨论

2:00 PM-

AS-0084: Clinical Outcomes of 6-Month vs. 12-Month Dual Antiplatelet Therapy after Implantation of Long Biodegradable Polymer Drug-Eluting Stents - A Subgroup Analysis from I-LOVE-IT 2 Trial
AS-0084:置入生物涂层可降解长支架后口服6个月和12个月双联抗血小板药物治疗临床观察
Jing Qi 齐静

2:10 PM-

Q&A
讨论

2:15 PM-

AS-0087: Development and Validation of a Scoring System for Predicting Long-Term Ischemic Events in Patients with Coronary Artery Disease
AS-0087:预测冠心病患者长期缺血预后的一个评分系统的推导和验证
Yaling Han 韩雅玲

2:25 PM-

Q&A
讨论

2:30 PM-

AS-0089: Six vs. 12 Months of Dual Antiplatelet Therapy after Implantation of Biodegradable Polymer Sirolimus-Eluting Stent in Elder Patients: A Subgroup Analysis of the I-LOVE-IT 2 Trial
AS-0089:老年患者植入新型药物洗脱支架术后6个月与12个月双联抗血小板治疗的有效性和安全性分析
Jing Yang 杨靖

2:40 PM-

Q&A
讨论

2:45 PM-

AS-0141: A Randomized Comparison of Biodegradable Polymer- and Permanent Polymer-Coated Platinum Chromium Everolimus-Eluting Coronary Stents in China: EVOLVE China Study
AS-0141:评估SYNERGY支架系统治疗冠状动脉粥样硬化病变安全性和有疗效性的前瞻、随机对照的多中心研究(EVOLVE中国)
Yaling Han 韩雅玲

2:55 PM-

Q&A
讨论

3:00 PM-

Adjourn
休会